NCT00903604View on ClinicalTrials.gov

Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Cardiac SurgeryCoronary Artery Bypass GraftingValve SurgeryAortic Root or Ascending Aortic Aneurysm Repair Surgery
Interventions
DRUG

AP214

Three 10-minutes infusions of sequential ascending dosages of AP214

DRUG

Placebo

Three 10-minutes infusions of isotonic saline solution

Trial Locations (2)

2100

Department of Cardiac and Thoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen

5000

Odense University Hospital, Department of Cardiac, Thoracic and Vascular Surgery, Odense

Sponsors

Lead Sponsor

Action Pharma A/S
All Listed Sponsors
lead

Action Pharma A/S

INDUSTRY

NCT00903604 - Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter